Resolute Advisors’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$201K	Hold	57,526	–	–	0.08%	76
2025 Q4	$197K	Hold	57,526	–	–	0.06%	67
2025 Q3	$289K	Hold	57,526	–	–	0.07%	52
2025 Q2	$197K	Sell	57,526 -4,050	-7%	-$10.1K	0.05%	64
2025 Q1	$137K	Hold	61,576	–	–	0.04%	60
2024 Q4	$180K	Hold	61,576	–	–	0.04%	75
2024 Q3	$160K	Buy	61,576 +4,050	+7%	+$11.2K	0.03%	54
2024 Q2	$170K	Hold	57,526	–	–	0.04%	48
2024 Q1	$261K	Hold	57,526	–	–	0.05%	43
2023 Q4	$328K	Hold	57,526	–	–	0.04%	46
2023 Q3	$265K	Hold	57,526	–	–	0.04%	45
2023 Q2	$372K	Hold	57,526	–	–	0.04%	44
2023 Q1	$434K	Hold	57,526	–	–	0.05%	37
2022 Q4	$583K	Hold	57,526	–	–	0.08%	26
2022 Q3	$569K	Hold	57,526	–	–	0.07%	25
2022 Q2	$613K	Buy	57,526 +14,086	+32%	+$119K	0.06%	27
2022 Q1	$424K	Hold	43,440	–	–	0.02%	45
2021 Q4	$621K	Hold	43,440	–	–	0.02%	37
2021 Q3	$871K	Buy	+43,440	New	+$768K	0.12%	32